跳至主要内容
临床试验/CTRI/2021/03/032056
CTRI/2021/03/032056招募中3 期

Assessment of inflammatory markers in patients with respiratory illness and the role of cardamom extract and 1-8 cineol in controlling associated inflammation

Zum Heilen Diagnostic Therapeutics ZH DT0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age group 19 â?? 70 yrs
  • 2.Subjects of both male and females involved
  • 3.Patients with acute respiratory infections
  • 4.Subjects who are willing to provide written consent for the study
  • 5.Mild to Moderately severe disease (NEWS score Less than/equal to 8)
  • 6.Can take oral medicines
  • 7.Subject willing to abide by and comply with the study protocol

排除标准

  • 1.Subjects less than 17 years and above 70yrs old
  • 2.Pregnancy and lactation
  • 3.Patients with existing history of other inflammatory disease conditions
  • 4.Patients currently taking anti-inflammatory drugs and
  • 5.Immune-compromised subjects
  • 6.Severe or complicated lung disease/infection
  • 7.Presence of acute hypoxic respiratory failure/ need for Intensive care unit (ICU) stay/ Patients who need mechanical ventilation.
  • 8.Any uncontrolled systemic disease, infection
  • 9.Those with serious Cardiovascular, Cerebrovascular, Respiratory, Liver or Renal disease or any other disorder.
  • 10.Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol

研究者

发起方
Zum Heilen Diagnostic Therapeutics ZH DT

相似试验